Europe clinical diagnostics market was valued at $16,808.4 million in 2021 and will grow by 7.0% annually over 2021-2031, driven by the rising patient awareness and rising demand for high-quality care amid the COVID-19 pandemic, growing healthcare spend, technological advancement, benefits of clinical diagnostics such as quick test results and easy procedure, increasing prevalence of chronic diseases caused due to sedentary lifestyle such as diabetes, cardiovascular diseases, high blood pressure, lipid disorders, kidney diseases and cancer.
Highlighted with 33 tables and 60 figures, this 115-page report “Europe Clinical Diagnostics Market 2021-2031 by Test (Lipid Panel, Infectious Disease Testing, Liver Panel, CBC), Product (Instruments, Assay Kits & Reagents, Software & Services), Indication (Cardiovascular, Cancer, Infectious Disease), Patient Gender (Male, Female), Age Group (44 and below, 45-64, 65 and over), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe clinical diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe clinical diagnostics market in every aspect of the classification from perspectives of by Test, Product, Indication, Patient Gender, Age Group, End User, and Country.
Based on Test, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Lipid Panel
• Infectious Disease Testing
• Liver Panel
• Complete Blood Count (CBC)
• Electrolyte Testing
• Renal Panel
• Other Tests
Based on Product, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Instruments
• Assay Kits & Reagents
• Software & Services
By Indication the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Cardiovascular
• Cancer
• Infectious Disease
• Stroke
• Chronic Lower Respiratory Diseases
• Diabetes
• Other Indications
By Patient Gender the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Male Patients
• Female Patients
By Age Group the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Age 44 and below
• Age 45-64
• Age 65 and over
By End User the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospital & Clinics Laboratory
• Diagnostic Laboratory
• Point-of-Care Testing
• Other End Users
Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of key national markets by Test, Product, and Indication, over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
• Abbott Laboratories
• Becton, Dickinson and Company
• BioMerieux SA
• Bio-Rad Laboratories Inc.
• Bio-Reference Laboratories
• Bioscientia Healthcare
• Charles River Laboratories
• Danaher Corporation
• Hoffmann-La Roche AG
• Hologic Inc.
• Qiagen NV
• Siemens Healthcare
• Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 22
2.2 Major Growth Drivers 24
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porter’s Fiver Forces Analysis 37
3 Segmentation of Europe Market by Test 41
3.1 Market Overview by Test 41
3.2 Lipid Panel 43
3.3 Infectious Disease Testing 44
3.4 Liver Panel 45
3.5 Complete Blood Count (CBC) 46
3.6 Electrolyte Testing 47
3.7 Renal Panel 48
3.8 Other Tests 49
4 Segmentation of Europe Market by Product 50
4.1 Market Overview by Product 50
4.2 Instruments 52
4.3 Assay Kits & Reagents 53
4.4 Software & Services 54
5 Segmentation of Europe Market by Indication 55
5.1 Market Overview by Indication 55
5.2 Cardiovascular 57
5.3 Cancer 58
5.4 Infectious Disease 59
5.5 Stroke 60
5.6 Chronic Lower Respiratory Diseases 61
5.7 Diabetes 62
5.8 Other Indications 63
6 Segmentation of Europe Market by Patient Gender 64
6.1 Market Overview by Patient Gender 64
6.2 Male Patients 66
6.3 Female Patients 67
7 Segmentation of Europe Market by Age Group 68
7.1 Market Overview by Age Group 68
7.2 Age 44 and below 70
7.3 Age 45-64 71
7.4 Age 65 and over 72
8 Segmentation of Europe Market by End User 73
8.1 Market Overview by End User 73
8.2 Hospital & Clinics Laboratory 75
8.3 Diagnostic Laboratory 76
8.4 Point-of-Care Testing 77
8.5 Other End Users 78
9 European Market 2021-2031 by Country 79
9.1 Overview of European Market 79
9.2 Germany 82
9.3 U.K. 85
9.4 France 87
9.5 Spain 89
9.6 Italy 91
9.7 Russia 93
9.8 Rest of European Market 95
10 Competitive Landscape 97
10.1 Overview of Key Vendors 97
10.2 New Product Launch, Partnership, Investment, and M&A 100
10.3 Company Profiles 101
Abbott Laboratories 101
Becton, Dickinson and Company 103
BioMerieux SA 104
Bio-Rad Laboratories Inc. 105
Bio-Reference Laboratories 106
Bioscientia Healthcare 107
Charles River Laboratories 108
Danaher Corporation 109
Hoffmann-La Roche AG 110
Hologic Inc. 111
Qiagen NV 112
Siemens Healthcare 113
Thermo Fisher Scientific 114
RELATED REPORTS 115
List of Tables:
Table 1. Snapshot of Europe Clinical Diagnostics Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Health Spending by Region, $ bn, 2013-2020 29
Table 4. Main Product Trends and Market Opportunities in Europe Clinical Diagnostics Market 33
Table 5. Europe Clinical Diagnostics Market by Test, 2021-2031, $ mn 41
Table 6. Europe Clinical Diagnostics Market by Product, 2021-2031, $ mn 50
Table 7. Europe Clinical Diagnostics Market by Indication, 2021-2031, $ mn 55
Table 8. Europe Clinical Diagnostics Market by Patient Gender, 2021-2031, $ mn 64
Table 9. Europe Clinical Diagnostics Market by Age Group, 2021-2031, $ mn 68
Table 10. Europe Clinical Diagnostics Market by End User, 2021-2031, $ mn 73
Table 11. Europe Clinical Diagnostics Market by Country, 2021-2031, $ mn 81
Table 12. Germany Clinical Diagnostics Market by Test, 2021-2031, $ mn 83
Table 13. Germany Clinical Diagnostics Market by Product, 2021-2031, $ mn 83
Table 14. Germany Clinical Diagnostics Market by Indication, 2021-2031, $ mn 83
Table 15. U.K. Clinical Diagnostics Market by Test, 2021-2031, $ mn 86
Table 16. U.K. Clinical Diagnostics Market by Product, 2021-2031, $ mn 86
Table 17. U.K. Clinical Diagnostics Market by Indication, 2021-2031, $ mn 86
Table 18. France Clinical Diagnostics Market by Test, 2021-2031, $ mn 88
Table 19. France Clinical Diagnostics Market by Product, 2021-2031, $ mn 88
Table 20. France Clinical Diagnostics Market by Indication, 2021-2031, $ mn 88
Table 21. Spain Clinical Diagnostics Market by Test, 2021-2031, $ mn 90
Table 22. Spain Clinical Diagnostics Market by Product, 2021-2031, $ mn 90
Table 23. Spain Clinical Diagnostics Market by Indication, 2021-2031, $ mn 90
Table 24. Italy Clinical Diagnostics Market by Test, 2021-2031, $ mn 92
Table 25. Italy Clinical Diagnostics Market by Product, 2021-2031, $ mn 92
Table 26. Italy Clinical Diagnostics Market by Indication, 2021-2031, $ mn 92
Table 27. Russia Clinical Diagnostics Market by Test, 2021-2031, $ mn 94
Table 28. Russia Clinical Diagnostics Market by Product, 2021-2031, $ mn 94
Table 29. Russia Clinical Diagnostics Market by Indication, 2021-2031, $ mn 94
Table 30. Clinical Diagnostics Market in Rest of Europe by Country, 2021-2031, $ mn 96
Table 31. Abbott Laboratories: Company Snapshot 101
Table 32. Abbott Laboratories: Business Segmentation 102
Table 33. Abbott Laboratories: Product Portfolio 102
